Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore blind people's sight.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.